Protein targeting

Lore & Background

Blobel, then an assistant professor at Rockefeller University, built upon the work of his colleague George Palade. Palade had previously demonstrated that non-secreted proteins were translated by free ribosomes in the cytosol, while secreted proteins were translated by ribosomes bound to the endoplasmic reticulum (ER). Candidate explanations at the time postulated a processing difference between free and ER-bound ribosomes, but Blobel hypothesized that protein targeting relied on characteristics inherent to the proteins, rather than a difference in ribosomes. Supporting his hypothesis, Blobel discovered that many proteins have a short amino acid sequence at one end that functions like a postal code specifying an intracellular or extracellular destination. Signal peptides serve as targeting signals, enabling cellular transport machinery to direct proteins to specific intracellular or extracellular locations. While no consensus sequence has been identified for signal peptides, many possess a characteristic tripartite structure: a positively charged, hydrophilic region near the N-terminal; a span of 10 to 15 hydrophobic amino acids near the middle; and a slightly polar region near the C-terminal. After a protein has reached its destination, the signal peptide is generally cleaved by a signal peptidase. Most mature proteins do not contain signal peptides. While most signal peptides are found at the N-terminal, in peroxisomes the targeting sequence is located on the C-terminal extension. Unlike signal peptides, signal patches are composed of amino acid residues that are discontinuous in the primary sequence but become functional when folding brings them together on the protein surface. Signal patches are not cleaved after sorting is complete.

Reader's Guide

Protein targeting is fundamental to cellular organization and function. The discovery of signal peptides by Günter Blobel, building on George Palade's earlier work, revolutionized understanding of how proteins reach their correct locations. This mechanism explains how secretory proteins, membrane proteins, and organelle-specific proteins are sorted. The process involves co-translational translocation, where a signal recognition particle (SRP) recognizes an N-terminal signal peptide on the nascent protein, pauses synthesis, and transfers the ribosome-protein complex to an SRP receptor on the ER membrane. There, the protein enters the translocon (Sec61 in eukaryotes, SecYEG in prokaryotes) and is either cleaved by signal peptidase or retained as a signal anchor. Post-translational translocation also occurs for some proteins, requiring cofactors like SecA and SecB in prokaryotes or Sec62/Sec63 in eukaryotes. Proteins targeted to mitochondria, chloroplasts, peroxisomes, or the nucleus use specialized post-translational pathways. Defects in protein sorting have been linked to multiple diseases, underscoring its medical importance. The field continues to explore complexities such as multi-transmembrane proteins that do not fit the standard model.

Did You Know?

• Signal peptides are generally 13 to 36 amino acids long and are cleaved after the protein reaches its destination.
• Most signal peptides are at the N-terminal, but in peroxisomes the targeting sequence is on the C-terminal extension.
• Signal patches are composed of amino acid residues that are discontinuous in the primary sequence but become functional when folding brings them together.
• Seven transmembrane G-protein coupled receptors mostly lack an N-terminal signal sequence; their first transmembrane domain acts as the signal sequence.

The Molecular Landscape of Cellular Activity

Molecular biology occupies a unique position at the crossroads of genetics and biochemistry, seeking to decode the physical and chemical machinery that drives life at the smallest scales. At its core, the discipline interrogates how nucleic acids—DNA and RNA—and proteins are structured, how they function, and how they interact with one another to orchestrate essential processes like replication, transcription, translation, and protein synthesis. This is not a single-discipline endeavor; it draws heavily on principles from physics, mathematics, and more recently computer science through bioinformatics. The field only became viable in the twentieth century, when analytical tools developed in physics and chemistry matured enough to be applied to biological questions. Before that, even though cells had been observed under microscopes as early as the eighteenth century, the deeper mechanisms governing their behavior remained largely invisible. The term itself was first applied in 1945 by English physicist William Astbury, who envisioned an approach that would uncover the physical underpinnings of biological phenomena and explain observations made at larger organizational scales.

The Double Helix and a New Physico-Chemical Language

The 1953 description of DNA's double helical structure stands as perhaps the single most consequential moment for the emerging field. Francis Crick and James Watson, working at the Medical Research Council Unit in the Cavendish Laboratory, proposed the model after building on X-ray crystallography data produced by Rosalind Franklin, which reached them through Maurice Wilkins and Max Perutz. What made the discovery transformative was not merely the elegant geometry but the fact that it supplied a concrete physico-chemical basis for understanding how biological inheritance operates at the molecular level. Before this, the idea that nucleic acids served as the primary carriers of hereditary information remained somewhat abstract. The structure also opened the door to discovering DNA in microorganisms, plants, and animals, broadening the scope of genetic research enormously. Watson and Crick, together with Wilkins, received the 1962 Nobel Prize in Physiology or Medicine for proposing the structural model, cementing the event as a landmark in the history of molecular biology.

From Triplet Codes to the Protein Synthesis Machinery

Understanding how genetic information translates into functional proteins required a series of incremental breakthroughs in the early 1960s. In 1961, researchers demonstrated that when a gene encodes a protein, three sequential bases in the DNA specify each successive amino acid, establishing the genetic code as a non-overlapping triplet system read from a fixed starting point. This finding laid the groundwork for deciphering how the cellular machinery assembles proteins. Between 1962 and 1964, the use of conditional lethal mutants of a bacterial virus drove fundamental advances in understanding the proteins involved in DNA replication, repair, recombination, and the assembly of complex molecular structures. These studies revealed the intricate interplay of multiple protein factors working in concert. The broader context traces back further: Gregor Mendel's 1866 laws of inheritance in pea plants, Friedrich Miescher's 1869 identification of nuclein in pus-filled bandages, Phoebus Levene's 1919 polynucleotide model from yeast experiments, and Erwin Chargaff's 1950 rule linking purine and pyrimidine concentrations all contributed the conceptual scaffolding upon which the protein-coding machinery was eventually understood.

From Bench to Bedside: Molecular Tools in Medicine

The practical reach of molecular biology extends well beyond the laboratory bench into clinical practice and therapeutic development. The techniques the field has cultivated enable scientists to probe molecular processes with precision, and these same tools are now deployed to efficiently target new drugs, diagnose disease, and deepen understanding of cell physiology. Where clinical research and medical therapies emerge directly from molecular-level interventions in genetic material, the work falls under the umbrella of gene therapy. More broadly, the application of molecular biology or molecular cell biology principles within medicine has come to be known as molecular medicine, a designation that reflects the field's growing integration into everyday clinical decision-making. This translational dimension gives the discipline a dual identity: it remains a fundamental science concerned with the structure and interaction of macromolecules, yet it simultaneously serves as an engine for practical innovation in how diseases are identified, understood, and treated. The multi-disciplinary nature of the field—spanning genetics, biochemistry, physics, mathematics, and bioinformatics—ensures that its medical applications continue to evolve as new analytical and computational tools become available.